60
Participants
Start Date
September 22, 2022
Primary Completion Date
July 18, 2024
Study Completion Date
July 18, 2024
RO7486967
For up to approximately 28 days
Placebo
For up to approximately 28 days
Weill Cornell Medical College, New York
University Pennsylvania Hospital, Philadelphia
Georgetown University, Washington D.C.
Advent Health Orlando, Orlando
University of Alabama at Birmingham, Birmingham
Quest Research Institute, Farmington Hills
The Movement Disorder Clinic of Oklahoma, Tulsa
CenExel Rocky Mountain Clinical Research, LLC, Englewood
Cedars Sinai Medical Center, Los Angeles
Brain Research Center B.V, Amsterdam
UMC St Radboud, Nijmegen
Brain Research Center Zwolle, Zwolle
University of Exeter, Exeter
Barts Health NHS Trust, London
Imperial College Healthcare NHS Trust; Charing Cross Hospital, London
National Hospital for Neurology and Neurosurgery; Leonard Wolfson Experimental Neurology Centre CRF, London
Campus for Ageing & Vitality; Clincal Ageing Research Unit, Newcastle
Hoffmann-La Roche
INDUSTRY